Narayana Hrudayalaya Limited has announced a scheduled investor meeting with institutional investors, informing both major stock exchanges as part of regulatory compliance requirements.

Meeting Details and Participants

The healthcare company has scheduled a physical group meeting with institutional investors on March 27, 2026, at 10:30 A.M. IST. The meeting participants include Premji, Magma & Arohi, with arrangements facilitated by ICICI Securities.

Regulatory Compliance

The company has submitted this intimation to stock exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification was filed on March 25, 2026, with both BSE Limited and National Stock Exchange of India Limited.

The intimation specifically references Regulation 30 read with Para A of Part A of Schedule III of the SEBI regulations, ensuring compliance with disclosure requirements for investor meetings.

Important Considerations

Narayana Hrudayalaya Limited has noted that the meeting schedule remains tentative and may be subject to changes due to exigencies on the part of analysts, investors, or the company itself. This flexibility clause allows for adjustments based on unforeseen circumstances that may affect any of the participating parties.

The notification was digitally signed by Sridhar S., Group Company Secretary, Legal & Compliance Officer, on March 25, 2026, at 22:22:43 +05'30', demonstrating the company's commitment to proper documentation and regulatory compliance in investor relations activities.

Narayana hrudayalaya has announced an updated schedule for its management meeting with institutional investors and analysts, now set for March 23, 2026, in compliance with SEBI regulations. The healthcare company submitted the revised intimation on March 21, 2026, to both BSE and NSE under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Updated Meeting Details and Expanded Participation

The physical group meeting is now scheduled for Monday, March 23, 2026, from 10:00 AM to 5:00 PM (IST) and will include 62 institutional investors and analysts, representing a significant increase from the previously planned 17 participants. The extended timeframe and larger participant base demonstrate heightened investor interest in the healthcare company.

Comprehensive List of Participating Institutions

The meeting will include a diverse range of institutional investors spanning multiple categories:

Mutual Funds and Asset Management: Axis Mutual Fund, Motilal Oswal Mutual Fund, Invesco Mutual Fund, Franklin Templeton, DSP Investment Managers, PGIM India Asset Management, Edelweiss Asset Management, 360 One Asset Management, Morgan Stanley Asset Management, Quantum Asset Management, Groww Mutual Fund, ITI Mutual Fund, The Wealth Company Mutual Fund, SAMCO Asset Management Private Limited, and Whiteoak Capital Asset Management Limited.

Insurance Companies: Bajaj Allianz Life Insurance, ICICI Prudential Life Insurance, Tata AIA Life, Kotak Life Insurance, Birla Sunlife Insurance Company, PNB Metlife India Insurance Company Limited, and Aviva Life Insurance.

Investment Advisory and Capital Management: Karma Capital Advisors, Helios Capital Management Private Limited, Param Capital Research Private Limited, MSA Capital Partners, Chanakya Wealth Advisors, Value Quest, Unifi Capital Private Limited, IKIGAI Asset Managers Holdings, Piper Serica Advisors Private Limited, Electrum Portfolio Managers Private Limited, Kedaara Capital Advisors LLP, Samara Capital, AUM Fund Advisors LLP, Paragon Partners, New Vernon Advisory, and East72 Capital Management and Advisors.

Specialized Investment Firms: Fyers Genesis Fund, Authum Investment, GeeCee Investments, Lucky Investment Managers Private Limited, Nuvama Group, Incred AMC, Multiples Alternate Asset Management, N Sekhsaria Trust, Quest Investment, Nepean Capital, Perpetuity Health Emerging Fund AIF, and Thinqwise Wealth Managers.

Regulatory Compliance and Schedule Flexibility

The company has fulfilled its updated disclosure obligations by informing both stock exchanges about the rescheduled investor meeting. The intimation was submitted pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Narayana Health has noted that the schedule remains tentative and may be subject to changes due to exigencies on the part of analysts, investors, or the company. The expanded meeting represents a significant enhancement of the company's investor relations activities and demonstrates strong institutional interest in the healthcare provider's business prospects.